Novodiax
UEI: PMQHJUKNDRW9
• CAGE: 667S5
• DBA: NOVODYAX INC
Overview
Awardee Type
Parent
Company Description
Novodiax's rapid Immunohistochemistry (IHC) assays provide the simplicity of H&E with the sensitivity and specificity of IHC. Click to learn more...
Name
Novodiax
Website
Headquarters
Hayward, CA
United States
United States
Most Recent Award
Sept. 24, 2024
Calculating
Federal contract recipient
NOVODIAX, INC.
dba NOVODYAX INC
(UEI PMQHJUKNDRW9, CAGE 667S5)
is headquartered in Hayward CA.
Its primary registered NAICS is 325413 In-Vitro Diagnostic Substance Manufacturing.
The corporation
was founded in March 2009 and
federally registered in
October 2010.
Federal Award Analysis
Novodiax federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
NOVODIAX, INC.
DBA
NOVODYAX INC
UEI
PMQHJUKNDRW9
CAGE Code
667S5
Primary NAICS
SBA Certifications
None
Self Certifications
Asian-Pacific American Owned
Minority Owned Business
Self-Certified Small Disadvantaged Business
Minority Owned Business
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
March 18, 2009
Initial Registration
Oct. 26, 2010
Last Registration
June 17, 2025
Registration Activation
June 17, 2025
Registration Expiration
June 13, 2026
Fiscal Year End
December 31
Reported Entity Types
Foreign Owned
For Profit Organization
Manufacturer of Goods
For Profit Organization
Manufacturer of Goods
State of Incorporation
CA
Country of Incorporation
USA
Employees
<500
Reported NAICS
Reported PSC
Accepts Credit Cards
Yes